Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Minority Interest (2021 - 2025)

Jaguar Health (JAGX) has disclosed Minority Interest for 5 consecutive years, with -$1.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest fell 146.69% to -$1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.3 million, a 146.69% decrease, with the full-year FY2024 number at -$791000.0, down 1135.94% from a year prior.
  • Minority Interest was -$1.3 million for Q3 2025 at Jaguar Health, down from -$1.1 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $310000.0 in Q1 2023 to a low of -$1.3 million in Q3 2025.
  • A 5-year average of -$256687.5 and a median of -$56000.0 in 2022 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: skyrocketed 384.38% in 2023, then plummeted 1135.94% in 2024.
  • Jaguar Health's Minority Interest stood at $242000.0 in 2021, then changed by 0.0% to $242000.0 in 2022, then tumbled by 126.45% to -$64000.0 in 2023, then tumbled by 1135.94% to -$791000.0 in 2024, then crashed by 60.3% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Minority Interest are -$1.3 million (Q3 2025), -$1.1 million (Q2 2025), and -$952000.0 (Q1 2025).